CD63 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

526 results for “CD63”

Trials

View all 190 →

Exosomal Markers CD63 and CD9 in Vitiligo Before and After NB-UVB Therapy

20 participants · First posted Sep 1, 2026

A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

3 participants · First posted Oct 14, 2021

Supplementation With L-ornithine But Not L-arginine Increases Density of CD68+ and CD163+ Macrophages in Periodontitis

75 participants · First posted Sep 13, 2021

Drugs

View all 306 →

CD63 modulating humanized antibodies

CD33-TTC

News

View all 30 →

Apoptotic Extracellular Vesicles Emerge as Novel Biomarkers for Cancer and Neurodegenerative Disease Diagnosis

Sanofi Expands Oncology Pipeline with CD73 Inhibitor Ulelimumab Collaboration

Uliledlimab Shows Promise in Advanced NSCLC with High CD73 Expression

Page 1 of 53